Invited to give a presentation on GLUT2, he quickly gained the attention of people from Novo Nordisk when he briefly mentioned his work on the GLP-1 receptor at the end of his talk which he had not yet published
Sensitivity analyses showed consistent results, including restricting outcomes to inpatient visits, conducting an intention-to-treat analysis, applying a prevalent new user design, and substituting SGLT2 inhibitors with dipeptidyl peptidase-4 (DPP4) inhibitors as the active comparator
Its already approved, has solid research behind it, and is being prescribed by doctors across the country
Telehealth eliminates travel expenses, reduces time off work, and often offers lower consultation fees, making it a cost-effective healthcare solution
Injection Technique General subcutaneous guidance from clinical bestpractice resources [6]